🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
60 Servings
Other Combinations Product Type
33% Evidence Coverage

Supplement Facts — Evidence Check

100 mg
📊 Market median: 550.0mg (217 products) 📚 29 studies (Tier A: 0, B: 5)
This product: 100mg
DMAE
25 mg
📊 Market median: 100.0mg (108 products)
Median 100.0mg This product: 20mg

Other Ingredients

Dextrose Xylitol Modified Cellulose Natural flavor Magnesium Vegetable Stearate Monk Fruit Natural color

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (78% of products) Nutrient (22% of products)

Target Groups

Children 4 or More Years of Age Gluten Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take one soft chewable tablet in the morning and one in the afternoon. Do not exceed more than 3 tablets in a 24 hour period. Read warnings and only use as directed. For best results, please allow 30 days of use.

⚠️ Warnings & Precautions

Warnings: Not suitable for children under the age of 2.

Consult a health care professional prior to consumption if you have any pre-existing medical conditions or take prescription medication.

Improper use of product will not improve result and is potentially hazardous to a person's health. Use only as directed.

Keep out of reach of children to prevent accidental use.

🧪 Formulation Notes

Attention, focus and memory.

Stimulant free

Pediatrician created

For children ages 5 and up

Safe, effective Non habit-forming

Gluten free, non-GMO

Additional Information

Attention support by Creekside Natural Therapeutics Orange cream EZ-Melt tablets

ez Melts Nutrition that melts in your mouth

Visit us online at: Facebook Instagram YouTube

Product Details

DSLD Entry Date 2021-11-19
Product Type Other Combinations
Form Tablet or Pill
DSLD ID 255966
Data Updated 2026-04-11

Research Evidence

32 Research Sources
50 Avg Quality Score
19 Rct
7 Meta Analysis
3 Clinical Trial
2 Other
1 Systematic Review
B Greater Choline-Containing Compounds and Myo-inositol in Treatment-Resistant Versus Responsive Schizophrenia: A 1H-Magnetic Resonance Spectroscopy Meta-analysis
Meta Analysis Biological psychiatry. Cognitive neuroscience and neuroimaging 2024
B Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines
Meta Analysis The Journal of clinical endocrinology and metabolism 2024
B Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes
Meta Analysis The Cochrane database of systematic reviews 2023
B Effectiveness of inositol, metformin and their combination in women with PCOS undergoing assisted reproduction: systematic review and meta-analysis
Meta Analysis Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2022
B Effects of myo-inositol vs. metformin on hormonal and metabolic parameters in women with PCOS: a meta-analysis
Meta Analysis Irish journal of medical science 2023
B Inositol for subfertile women with polycystic ovary syndrome
Meta Analysis The Cochrane database of systematic reviews 2018
B Treatment of lean PCOS teenagers: a follow-up comparison between Myo-Inositol and oral contraceptives
Rct European review for medical and pharmacological sciences 2021
B The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios
Rct European review for medical and pharmacological sciences 2019
C Investigating the effect of combined use of selenium and Myo-inositol supplements on thyroid function and autoimmune characteristics in thyroid disorders: a systematic review and meta-analysis
Meta Analysis Expert review of endocrinology & metabolism 2024
C Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial.
Rct International journal of food sciences and nutrition
View all evidence for Inositol →

Compare Similar Products

View all Inositol products →